The current ELAB market cap is 10.19M. The company's latest EPS is USD -0.1039 and P/E is -5.49.
Quarter End | Sep 2023 |
---|---|
USD ($) | |
Total Revenue | 555k |
Operating Income | -1.33M |
Net Income | -784k |
Year End December 29 2022 | 2022 |
---|---|
USD ($) | |
Total Revenue | 766k |
Operating Income | -1.27M |
Net Income | -1.8M |
Quarter End | Sep 2023 |
---|---|
USD ($) | |
Total Assets | 1.58M |
Total Liabilities | 1.75M |
Total Equity | -164k |
Year End December 29 2022 | 2022 |
---|---|
USD ($) | |
Total Assets | 1.89M |
Total Liabilities | 761k |
Total Equity | 1.13M |
Market Cap | 10.19M |
Price to Earnings Ratio | -5.49 |
Price to Sales Ratio | 12.9 |
Price to Cash Ratio | 8.56 |
Price to Book Ratio | 8.73 |
Dividend Yield | - |
Shares Outstanding | 17.33M |
Average Volume (1 week) | 37.7k |
Average Volume (1 Month) | 58.06k |
52 Week Change | -85.30% |
52 Week High | 4.2442 |
52 Week Low | 0.56 |
Spread (Intraday) | 0.02 (3.04%) |
Company Name | Elevai Labs Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://elevailabs.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.